Refine Your Search

  • Solutions

  • Therapeutic Areas

  • Resource Type

Certara Launches its Cardiac Safety Simulator V2.0

New biosimulation solution addresses drug candidates’ cardiotoxicity risk PRINCETON, NJ – Apr. 2, 2015 – Certara®, the global biosimulation technology-enabled consultancy, today announced the launch of version 2.0 of its Cardiac Safety Simulator (CSS), which has become a standalone product for the first time. CSS is currently being used by several leading pharma companies, two […]

More Info

Physiologically-based Modeling Supports Drug Development Decisions, Regulatory Interactions and Drug Labeling

Today’s powerful and actively evolving computational tools enable sponsors and regulators to understand potential drug characteristics and subject responses earlier in development, with greater certainty. Model-based approaches support timely, confident decisions across the development and regulatory life cycle by gathering disparate sources of information about a drug, its competitors, target disease and patients into a […]

Solution: PBPK Modeling & Simulation
Therapeutic Area: Cardiovascular, Infectious Disease, Oncology/Hematology, Pediatrics
More Info
Learn More LinkedIn Twitter Facebook Email Subscribe to the Blog